Twist Bioscience revenue and financials
$205.00Change from previous close: +8.66%Absolute change: +$16.33
In the fiscal year ended September 2025, Twist Bioscience reported revenue of $376.57M (+20.32% year over year). The net loss was $77.67M.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +20.32%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- -20.6%
- FY to Sep 2024: -66.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 672 | 676 | 638 | 642 | 644 | 596 | 609 | 614 | 638 | 703 | 733 | 776 |
| Current assets | 321 | 323 | 304 | 333 | 340 | 338 | 345 | 347 | 362 | 372 | 390 | 424 |
| Cash and equivalents | 117 | 123 | 149 | 183 | 201 | 210 | 221 | 226 | 239 | 243 | 266 | 286 |
| Short-term investments | 49.4 | 49.0 | 49.4 | 49.4 | 49.4 | 46.7 | 49.4 | 50.1 | 50.3 | 50.0 | 44.9 | 49.9 |
| Receivables | 71.2 | 72.5 | 50.1 | 57.0 | 51.1 | 51.1 | 39.3 | 34.9 | 33.0 | 37.1 | 35.4 | 44.1 |
| Inventory | 35.2 | 33.5 | 32.9 | 28.3 | 25.9 | 20.9 | 23.5 | 24.1 | 28.5 | 30.4 | 30.9 | 32.1 |
| Net property, plant and equipment | 181 | 182 | 177 | 152 | 147 | 151 | 157 | 161 | 168 | 185 | 195 | 203 |
| Goodwill | 82.2 | 82.2 | 82.2 | 82.2 | 82.2 | 85.8 | 85.8 | 85.8 | 85.8 | 85.8 | 85.8 | 85.8 |
| Other intangible assets | 12.7 | 13.0 | 13.2 | 13.4 | 13.7 | 14.0 | 14.2 | 14.5 | 14.7 | 51.9 | 53.2 | 54.5 |
| Long-term investments | 68.1 | 68.1 | 54.3 | 54.3 | 54.3 | — | — | 1.5 | — | — | — | — |
| Current liabilities | 120 | 120 | 80.4 | 91.4 | 87.1 | 75.0 | 69.6 | 71.0 | 73.8 | 67.5 | 65.2 | 73.3 |
| Accounts payable | 17.0 | 14.7 | 12.5 | 11.1 | 12.0 | 8.1 | 7.5 | 1.6 | 6.6 | 7.7 | 9.3 | 14.1 |
| Long-term debt | 15.0 | 15.0 | 15.0 | 15.0 | 15.0 | 15.0 | 15.0 | — | — | — | — | — |
| Total debt | 93.6 | 95.8 | 98.1 | 75.6 | 78.2 | — | — | — | — | — | — | — |
| Total liabilities | 227 | 221 | 182 | 169 | 165 | 156 | 153 | 142 | 147 | 143 | 143 | 153 |
| Total equity (incl. minority) | 446 | 455 | 456 | 473 | 478 | 440 | 456 | 473 | 491 | 560 | 590 | 623 |
| Retained earnings | -1,429 | -1,394 | -1,350 | -1,320 | -1,292 | -1,313 | -1,274 | -1,242 | -1,207 | -1,122 | -1,076 | -1,033 |